Tolerance Bio
tolerancebio.com
Actively hiring
Biologics & Biosimilars
Biotechnology
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$32.3M
2 rounds on record
Latest round
$15.1M
Venture round · Jun 2026 · 4 mo ago
Team
51-200
employees, estimated range
The money's age
Fresh money
4 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 3
Raised a round Venture round $15.1M · SEC Form D
Sep 8, 2025
Partnership Tolerance Bio and Zipcode partner on thymus-targeting therapeutics · bioworld.com
Oct 20, 2024
Raised a round Seed $17.2M · Pulse 2.0
2023
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jun 2026 | $15.1M | — | SEC Form D |
| Seed | Oct 2024 | $17.2M | — | Pulse 2.0 |
Registers and programsofficial lists and records that name the company
| Legal entity | Tolerance Bio Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Philip BallExecutive Officer, DirectorSEC Form D
Justin VogelExecutive Officer, DirectorSEC Form D
Francisco LeonExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Leading the advancement of biologics for targeted immune regulation & restoration.
At Prellis Biologics, we harness AI and immune diversity to advance next-gen medicines. Discover our EXIS™ platform and bioprinting…
ApogeeTherapeutics. Apogee is seeking to reshape the current standard of care for inflammatory and immune diseases because we believe…
Puna Bio develops crop biologicals from extremophile microorganisms. Its strains come from high-altitude Argentine environments with harsh…
We improve the quality and efficiency of clinical trials, helping biopharmaceutical companies, CROs, and institutions facilitate the…
Nuance Pharma are an innovation focused biopharmaceutical company, with both late-stage clinical pipeline and commercial stage asset…
News
Tolerance Bio Licenses Clinical-Stage Long-Acting Interleukin-7 Therapy Efineptakin Alfa from NeoImmuneTech to Advance Programs Targeting Thymic Function and Immune Resilience
PHILADELPHIA, August 19, 2026--Tolerance Bio Licenses Clinical-Stage Long-Acting Interleukin-7 Therapy Efineptakin Alfa from NeoImmuneTech
Read more
Report
Beyond Celiac Investments Announces Investment in Tolerance Bio to Advance Novel Approach in Celiac Disease
Read more
Report
Tolerance Bio and Zipcode partner on thymus-targeting therapeutics
Tolerance Bio Inc. and Zipcode Bio have established a strategic research and development collaboration aimed at pioneering novel delivery methods for targeted thymus therapeutics.
Read more
Report
Tolerance Bio, Inc. Announces Scientific Advisory Board and Completion of $20.2 Million Seed Round to Advance Thymus-Based Therapies for Immune-Mediated Diseases
Read more
Report
Tolerance Bio: $17.2 Million (Seed) Raised To Increase Healthspan By Manipulating Thymus Functions
Tolerance Bio, a biopharmaceutical company pioneering a novel approach to increasing healthspan by preserving, restoring, and manipulating the function of the thymus, the master regulator of immune tolerance, announced the closing of its oversubscribed $1
Read more
Report
Tolerance Bio: $17.2 Million (Seed) Raised For Increasing Healthspan By Adjusting Function Of The Thymus
Tolerance Bio - a biopharmaceutical company pioneering a novel approach to increasing healthspan by preserving, restoring, and manipulating the function of the thymus, the master regulator of immune tolerance - announced the closing of its oversubscribed
Read more
Report
Tolerance Bio, Inc. Launches With $17.2 Million in Seed Financing to Advance Thymus-Based Therapies for Immune-Mediated Diseases
Tolerance Bio, Inc., a biopharmaceutical company pioneering a novel approach to increasing healthspan by preserving, restoring, and manipulating the function...
Read more
Report
People
Philip Ball
Executive Officer, Director
Justin Vogel
Executive Officer, Director
Francisco Leon
Executive Officer, Director
Damia Carulla
Director
Pablo Cironi
Director
Robert Goldstein
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Philadelphia
United States
HQ
50-200 est. staff